Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of <i>EGFR</i> mutations in NSCLC: a new algorithm for patient selection and personalized treatment.

Oncotarget·2020
Same author

Combining Ubiquinol With a Statin May Benefit Hypercholesterolaemic Patients With Chronic Heart Failure.

Heart, lung & circulation·2019
Same author

The Role of Gas Exchange Variables in Cardiopulmonary Exercise Testing for Risk Stratification and Management of Heart Failure with Reduced Ejection Fraction.

American heart journal·2018
Same author

Mineralocorticoid receptor antagonists for heart failure: a real-life observational study.

ESC heart failure·2018
Same author

Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.

European journal of heart failure·2017
Same author

Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database.

European journal of heart failure·2017

Related Experiment Video

Updated: May 18, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

10-year exercise training in chronic heart failure: a randomized controlled trial.

Romualdo Belardinelli1, Demetrios Georgiou, Giovanni Cianci

  • 1Department of Cardiovascular Sciences, Sections of Cardiac Rehabilitation and Prevention, Lancisi Heart Institute, Ancona, Italy. r.belardinelli@ospedaliriuniti.marche.it

Journal of the American College of Cardiology
|September 25, 2012
PubMed
Summary

This 10-year study shows that moderate exercise training (ET) for chronic heart failure (CHF) patients significantly improves functional capacity and quality of life, while reducing hospitalizations and cardiac mortality.

More Related Videos

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice
09:19

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice

Published on: February 2, 2019

Related Experiment Videos

Last Updated: May 18, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice
09:19

Short Session High Intensity Interval Training and Treadmill Assessment in Aged Mice

Published on: February 2, 2019

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Rehabilitation Medicine

Background:

  • Previous research indicated long-term moderate exercise training (ET) benefits functional capacity and quality of life in chronic heart failure (CHF) patients (NYHA class II-III).
  • The impact of very long-term (10-year) exercise programs on CHF patients remained largely unknown.

Purpose of the Study:

  • To investigate the effects of a 10-year supervised exercise training program on functional capacity, quality of life, and clinical outcomes in stable CHF patients.
  • To determine if sustained moderate exercise can maintain peak oxygen consumption (Vo(2)) above 60% of predicted maximum.

Main Methods:

  • 123 stable CHF patients were randomized into a trained (T) group (n=63) or a non-trained (NT) group (n=60).
  • The T group underwent supervised ET (60% peak Vo(2)) twice weekly for 10 years.
  • The NT group did not engage in formal exercise.

Main Results:

  • The T group maintained peak Vo(2) >60% of predicted maximum throughout the 10 years, unlike the NT group where it progressively declined.
  • The T group showed a significantly lower ventilation relative to carbon dioxide output (VE/Vco(2)) slope (35 ± 9 vs. 42 ± 11).
  • Quality of life scores were significantly better in the T group (43 ± 12 vs. 58 ± 14).
  • The T group experienced significantly lower hospital readmission rates (HR: 0.64) and cardiac mortality (HR: 0.68) over 10 years.
  • Peak Vo(2) and resting heart rate were identified as independent predictors of cardiovascular events.

Conclusions:

  • Moderate supervised ET, performed twice weekly for 10 years, effectively maintains functional capacity (>60% max Vo(2)) in CHF patients.
  • This sustained exercise regimen leads to significant improvements in quality of life compared to non-trained patients.
  • These benefits translate to a reduced incidence of major cardiovascular events, including CHF hospitalizations and cardiac mortality.